These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 26315369)

  • 21. [Update on current care guidelines: evaluation and treatment of menorrhagia].
    Duodecim; 2010; 126(8):913-4. PubMed ID: 20597336
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inter-rater agreement in the diagnosis of adenomyosis by 2- and 3-dimensional transvaginal ultrasonography.
    Rasmussen CK; Hansen ES; Dueholm M
    J Ultrasound Med; 2019 Mar; 38(3):657-666. PubMed ID: 30182497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insertion of the Mirena intrauterine system for treatment of adenomyosis-associated menorrhagia: a novel method.
    Peng FS; Wu MY; Yang JH; Chen SU; Ho HN; Yang YS
    Taiwan J Obstet Gynecol; 2010 Jun; 49(2):160-4. PubMed ID: 20708521
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of a levonorgestrel-releasing intrauterine device in the treatment of adenomyosis associated heavy menstrual bleeding.
    Uysal A; Taner CE; Mun S; Uysal F; Celimli FH
    J Pak Med Assoc; 2013 Nov; 63(11):1349-52. PubMed ID: 24392517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adenomyosis - diagnostic and therapeutic challenge].
    Seikkula J; Niinimäki M; Suvitie P
    Duodecim; 2016; 132(9):836-43. PubMed ID: 27319081
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathological findings associated with the presence of a mirena intrauterine system at hysterectomy.
    Rizkalla HF; Higgins M; Kelehan P; O'Herlihy C
    Int J Gynecol Pathol; 2008 Jan; 27(1):74-8. PubMed ID: 18156979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A giant adenomyotic cyst originating from the cervix.
    Isik Y; Dag ZO; Celik H
    Int J Gynaecol Obstet; 2015 Nov; 131(2):205-6. PubMed ID: 26341177
    [No Abstract]   [Full Text] [Related]  

  • 28. Moesin overexpression is a unique biomarker of adenomyosis.
    Ohara R; Michikami H; Nakamura Y; Sakata A; Sakashita S; Satomi K; Shiba-Ishii A; Kano J; Yoshikawa H; Noguchi M
    Pathol Int; 2014 Mar; 64(3):115-22. PubMed ID: 24698421
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overview of perimenopausal contraception.
    Bitzer J
    Climacteric; 2019 Feb; 22(1):44-50. PubMed ID: 30562124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mirena (Levonorgestrel intrauterine system): a successful novel drug delivery option in contraception.
    Rose S; Chaudhari A; Peterson CM
    Adv Drug Deliv Rev; 2009 Aug; 61(10):808-12. PubMed ID: 19445984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resources and procedures in the treatment of heavy menstrual bleeding with the levonorgestrel-releasing intrauterine system (LNG-IUS) or hysterectomy in Brazil.
    Bahamondes MV; de Lima Y; Teich V; Bahamondes L; Monteiro I
    Contraception; 2012 Sep; 86(3):244-50. PubMed ID: 22459236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathology and Pathogenesis of Adenomyosis.
    Antero MF; Ayhan A; Segars J; Shih IM
    Semin Reprod Med; 2020 May; 38(2-03):108-118. PubMed ID: 33080632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of menorrhagia with an LNG-IUS.
    Pakarinen P; Luukkainen T
    Contraception; 2007 Jun; 75(6 Suppl):S118-22. PubMed ID: 17531601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guideline No. 437: Diagnosis and Management of Adenomyosis.
    Dason ES; Maxim M; Sanders A; Papillon-Smith J; Ng D; Chan C; Sobel M
    J Obstet Gynaecol Can; 2023 Jun; 45(6):417-429.e1. PubMed ID: 37244746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenomyosis: An update regarding its diagnosis and clinical features.
    Bourdon M; Santulli P; Marcellin L; Maignien C; Maitrot-Mantelet L; Bordonne C; Plu Bureau G; Chapron C
    J Gynecol Obstet Hum Reprod; 2021 Dec; 50(10):102228. PubMed ID: 34520877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Medical and surgical management of adenomyosis.
    Farquhar C; Brosens I
    Best Pract Res Clin Obstet Gynaecol; 2006 Aug; 20(4):603-16. PubMed ID: 16563872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal uterine bleeding: Taking the stress out of controlling the flow.
    Farrukh JB; Towriss K; McKee N
    Can Fam Physician; 2015 Aug; 61(8):693-7. PubMed ID: 26273083
    [No Abstract]   [Full Text] [Related]  

  • 38. Adenomyosis: Diagnosis and Management.
    Schrager S; Yogendran L; Marquez CM; Sadowski EA
    Am Fam Physician; 2022 Jan; 105(1):33-38. PubMed ID: 35029928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenomyosis and Endometrial Cancer: Literature Review.
    Habiba M; Pluchino N; Petignat P; Bianchi P; Brosens IA; Benagiano G
    Gynecol Obstet Invest; 2018; 83(4):313-328. PubMed ID: 29874641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uterine polyps, adenomyosis, leiomyomas, and endometrial receptivity.
    Munro MG
    Fertil Steril; 2019 Apr; 111(4):629-640. PubMed ID: 30929720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.